Evidence map›Paper›PMID 26324887›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

p63 supports aerobic respiration through hexokinase II.

Guiditta Viticchiè, Massimiliano Agostini, Anna Maria Lena, Mara Mancini, Huiqing Zhou, Lello Zolla, David Dinsdale, Gaelle Saintigny, Gerry Melino, Eleonora Candi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. p63 and ZNF148 cooperate to regulate head and neck squamous cell carcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. The dual role of p63 in cancer.Frontiers in oncology · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Structural diversity of p63 and p73 isoforms.Cell death and differentiation · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Guiditta ViticchièDepartment of Experimental Medicine and Surgery, University of "Tor Vergata", 00133 Rome, Italy;
Massimiliano AgostiniDepartment of Experimental Medicine and Surgery, University of "Tor Vergata", 00133 Rome, Italy; Toxicology Unit, Medical Research Council, Leicester LE1 9HN, United Kingdom;
Anna Maria LenaDepartment of Experimental Medicine and Surgery, University of "Tor Vergata", 00133 Rome, Italy;
Mara ManciniDepartment of Experimental Medicine and Surgery, University of "Tor Vergata", 00133 Rome, Italy; Toxicology Unit, Medical Research Council, Leicester LE1 9HN, United Kingdom;
Huiqing ZhouDepartment of Molecular Developmental Biology, Radboud University, 6525 GA Nijmegen, The Netherlands;
Lello ZollaDepartment of Ecological and Biological Sciences, Tuscia University, 01100 Viterbo, Italy;
David DinsdaleToxicology Unit, Medical Research Council, Leicester LE1 9HN, United Kingdom;
Gaelle SaintignyChanel Parfumes Beauté, F-92521 Neuilly-sur-Seine, France;
Gerry MelinoDepartment of Experimental Medicine and Surgery, University of "Tor Vergata", 00133 Rome, Italy; Toxicology Unit, Medical Research Council, Leicester LE1 9HN, United Kingdom; candi@uniroma2.it gm89@le.ac.uk.
Eleonora CandiDepartment of Experimental Medicine and Surgery, University of "Tor Vergata", 00133 Rome, Italy; Istituto Dermopatico dell'Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico, 00167 Rome, Italy candi@uniroma2.it gm89@le.ac.uk.
University of Rome Tor Vergata · ITUniversity of Leicester · GBIstituto Dermopatico dell'Immacolata · ITMedical Research Council · GBRadboud University Nijmegen · NLUniversità degli Studi della Tuscia · IT

Funding

Medical Research Council MC_U132670600
6 · The paper itself

Abstract

Short p63 isoform, ΔNp63, is crucial for epidermis formation, and it plays a pivotal role in controlling the turnover of basal keratinocytes by regulating the expression of a subset of genes involved in cell cycle and cell adhesion programs. The glycolytic enzyme hexokinase 2 (HK2) represents the first step of glucose utilization in cells. The family of HKs has four isoforms that differ mainly in their tissue and subcellular distribution. The preferential mitochondrial localization of HK2 at voltage-dependent anion channels provides access to ATP generated by oxidative phosphorylation and generates an ADP/ATP recycling mechanism to maintain high respiration rates and low electron leak. Here, we report that ΔNp63 depletion in human keratinocytes impairs mitochondrial basal respiration and increases mitochondrial membrane polarization and intracellular reactive oxygen species. We show ΔNp63-dependent regulation of HK2 expression, and we use ChIP, validated by p63-Chip sequencing genomewide profiling analysis, and luciferase assays to demonstrate the presence of one p63-specific responsive element within the 15th intronic region of the HK2 gene, providing evidence of a direct interaction. Our data support the notion of ΔNp63 as a master regulator in epithelial cells of a combined subset of molecular mechanisms, including cellular energy metabolism and respiration. The ΔNp63-HK2 axis is also present in epithelial cancer cells, suggesting that ΔNp63 could participate in cancer metabolic reprogramming.

Indexed as

AnimalsCell ProliferationCell SeparationFlow CytometryGene SilencingGlycolysisHexokinaseHumansHydrogen PeroxideKeratinocytesMiceMicroscopy, ElectronMitochondriaMitochondrial MembranesNeoplasmsNIH 3T3 CellsHexokinaseHydrogen PeroxideOxygenTP53 protein, humanTP63 protein, humanTranscription FactorsTumor Suppressor Protein p53Tumor Suppressor ProteinsHK2keratinocytesmitochondriaoxidative metabolismp63

Identifiers

PMID26324887
PMCPMC4577137
OpenAlexW1898402870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.